[The use of the enterosorbent polifepan in the combined treatment of patients with dermatoses].
Polyfepan, an enterosorbent, was used in the treatment of 96 dermatologic patients. The treatment proved to be effective in those with toxicoderma, secondary xanthomatosis, porphyria cutanea tarda, skin itching, and urticaria, particularly in the cases when toxic exposures and gastrointestinal conditions contributed to the disease pathogenesis. Polyfepan enterosorption is harmless, well-tolerated, and simple.
Raznatovskiĭ
I M
IM
Mikheev
G N
GN
Monakhov
G N
GN
Levanova
V P
VP
Gvozdeva
E N
EN
Boĭko
T A
TA
D003131:Combined Modality Therapy; D004341:Drug Evaluation; D016061:Enterosorption; D006801:Humans; D008031:Lignin / Q000627:therapeutic use*; D012871:Skin Diseases / Q000628:therapy*; D013997:Time Factors
C056995:polyfepan; D008031:Lignin
Primenenie énterosorbenta polifepana v kompleksnom lechenii bol'nykh nekotorymi dermatozami.